Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Biomedical Engineering

Date Submitted: Jun 21, 2022
Open Peer Review Period: Jun 20, 2022 - Aug 15, 2022
Date Accepted: Jul 10, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A Wearable Vibratory Device (The Emma Watch) to Address Action Tremor in Parkinson Disease: Pilot Feasibility Study

Pacheco A, van Schaik T, Paleyes N, Blacutt M, Vega J, Schreier AR, Zhang H, Macpherson C, Desai R, Jancke G, Quinn L

A Wearable Vibratory Device (The Emma Watch) to Address Action Tremor in Parkinson Disease: Pilot Feasibility Study

JMIR Biomed Eng 2023;8:e40433

DOI: 10.2196/40433

PMID: 38875672

PMCID: 11041244

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Feasibility and preliminary efficacy of a wearable device that provides vibration in improving handwriting and hand function in individuals with action tremor

  • Alissa Pacheco; 
  • Tempest van Schaik; 
  • Nadzeya Paleyes; 
  • Miguel Blacutt; 
  • Julio Vega; 
  • Abigail R. Schreier; 
  • Haiyan Zhang; 
  • Chelsea Macpherson; 
  • Radhika Desai; 
  • Gavin Jancke; 
  • Lori Quinn

ABSTRACT

Background:

Action tremor is a debilitating symptom of Parkinson’s Disease (PD) and there is a need for effective interventions. The Microsoft Emma Watch, a wristband with five vibrating motors, is a non-invasive, non-pharmaceutical intervention for tremor attenuation.

Objective:

This pilot study investigated the use of the Emma Watch device to attenuate action tremor in people with PD (PwPD).

Methods:

The sample included nine PwPD who were assessed on handwriting and hand function tasks. The tasks were completed with the Emma Watch at a high vibration intensity, a low intensity (sham), and compared these to their baseline (no vibration) to see if there were changes in performance.

Results:

Results indicated there were no significant differences found in the outcomes of interest measured with the tablet (duration, mean velocity, number of peaks, pause time, and number of pauses). Acceleration and jerk variables measured by APDM did not have significant differences between vibration intensities, except for normalized acceleration peaks, where a main effect of frequency was found. However, a post-hoc Tukey test revealed no pairwise differences between vibration intensities.

Conclusions:

There were visually depicted and subjectively reported improvements in handwriting for a small subset of individuals. Our study did not indicate significant differences in any outcome measures. Future studies may benefit from a larger sample size and should focus on finding safe and effective ways to address Parkinson-induced action tremor and combining the Emma Watch with task specific training to study its effect on increasing hand function and/or writing ability.


 Citation

Please cite as:

Pacheco A, van Schaik T, Paleyes N, Blacutt M, Vega J, Schreier AR, Zhang H, Macpherson C, Desai R, Jancke G, Quinn L

A Wearable Vibratory Device (The Emma Watch) to Address Action Tremor in Parkinson Disease: Pilot Feasibility Study

JMIR Biomed Eng 2023;8:e40433

DOI: 10.2196/40433

PMID: 38875672

PMCID: 11041244

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.